Glenmark Pharmaceuticals Limited (Glenmark) marked May as the Hypertension Awareness Month. Glenmark partnered with more 18,000 healthcare professionals (HCPs) from more than 8000 hospitals and clinics in 50 cities across the country, and organized more than 110 public awareness rallies and 8000 screening camps to create mass awareness around Hypertension (High Blood Pressure).
The rallies comprised a detailed session by an HCP on the signs, symptoms as well as preventive measures around Hypertension; and were followed by screening camps for the general public. Through this initiative, the company was able to spread awareness amongst more than 2 lakh adults. Being the innovator of one of the path-breaking anti-Hypertension drugs, Telma, Glenmark has been leading from the front in increasing awareness and diagnosis of the disease among the Indian population. The company has already reached out to more than 1.2 million Indian adults through multiple channels. Noteworthy, Hypertension is one of the most important risk factors for cardiovascular diseases (CVD), particularly ischemic heart disease and stroke. Currently, it is estimated that 28.1% of all deaths in India were due to CVD, and high systolic blood pressure (SBP) was the single largest contributor (8.5%) to disability-adjusted life years (DALYs).
